Loading data for BLFS — first visit, this takes a few seconds.

BioLife Solutions, Inc.

NasdaqCM: BLFS · 实时价格 · USD
35.47
-1.60 (-4.32%)
收盘价: Aug 31, 2026, 8:00 PM

股价、关键数字和最新消息,都在这一页。

BioLife Solutions, Inc.(BLFS)股价、分析与数据

暂无数据

买价36.59
市值1.81B
营收(TTM)107M
净利润(TTM)49.2M
1.90
1
37.07
112.33
市净率(TTM)4.31
市销率(TTM)16.99
财报日期Aug 12, 2021
卖价46.5
成交量945,731
20日均量1,106,817
开盘价36.98
前收盘价37.07
日内区间35.12 - 37.25
52周区间17.86 - 38.10
分析师n/a
目标价n/a
分红n/a
除息日n/a

关于 BLFS

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media ...

板块 Healthcare
上市日期 Nov 22, 1989
员工人数 155
交易所 NasdaqCM
股票代码 BLFS
公司完整简介

财务表现

2025年,BioLife Solutions的营收为96.21M,较上一年的74.65M增长28.89%。 净利润为-4.6M,下降-77.23%。

财务报表

财报意外

BioLife Solutions 已于 Aug 6, 2026 发布季度财报:
  • 营收为 $28.47M 低于预期 $0, , 21.45% 同比增长.
  • 每股收益为 0.08 超出预期 0.02, , 700.00% 同比增长.
BioLife Solutions, Inc. 的下次财报预计于 Aug 12, 2021, 收盘后。
分析师预计营收为 ... 升级
第 1 页,共 2 页